Rash Completed Phase 2 Trials for Erlotinib (DB00530)

Back to Rash

Also known as: Skin Rash / Rashes / Skin rashes / Rash event / Rash (nonspecific) / Efflorescence / Rash NOS / Rash and other nonspecific skin eruption / Exanthem / Exanthema / Skin eruption / Eruption (disorder) / Eruption (morphologic abnormality) / Eruption

Indication	Status	Phase
DBCOND0019898 (Rash)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00473083	Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer	Treatment	Clindamycin (DB01190) Erlotinib (DB00530) Hydrocortisone (DB00741) Minocycline (DB01017) Triamcinolone (DB00620)